FIELD: medicine.
SUBSTANCE: invention refers to using the compound for treating and/or preventing infectious influenza virus disease, wherein said compound has the following formula:
,
where P is hydrogen or a group selected from the following formulas: a) -C(=O)-PR0, g) -C(=O)-O-PR2, i) -C(=O)-O-L-O-PR2, l) -C(PR3)2-O-C(=O)-PR4, m) -C(PR3)2-O-C(=O)-O-PR4 and o) -C(PR3)2-O-C(=O)-O-L-O-PR4, where L is a straight or branched alkylene; PR0 is alkyl; PR2 is alkyl; PR3 is hydrogen; and PR4 is alkyl.
EFFECT: treatment and/or prevention of infectious disease of influenza virus.
40 cl, 5 dwg, 51 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG FOR INFLUENZA TREATMENT, CHARACTERIZED BY THE FACT THAT IT COMBINES A PER-DEPENDENT ENDONUCLEASE INHIBITOR AND A DRUG AGAINST FLU | 2016 |
|
RU2745071C2 |
| SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF | 2016 |
|
RU2712275C2 |
| 1,4,5-TRISUBSTITUTED IMIDAZOLE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2196139C2 |
| ANTI-VIRAL COMPOSITIONS OF WIDE SPECTRUM OF ACTION AND METHODS | 2018 |
|
RU2813125C2 |
| ARYL-N-ARYL DERIVATIVES FOR TREATING RNA VIRAL INFECTION | 2019 |
|
RU2815493C2 |
| ARYL-N-ARYL DERIVATIVES FOR TREATING RNA VIRAL INFECTION | 2020 |
|
RU2821414C2 |
| ANTIVIRAL AGENTS AND USE THEREOF | 2015 |
|
RU2730453C2 |
| PHENYL-N-QUINOLINE DERIVATIVES FOR TREATMENT OF RNA VIRAL INFECTION | 2019 |
|
RU2805064C2 |
| IMIDAZOQUINOLINE COMPOUNDS | 2005 |
|
RU2415857C2 |
| HETEROCYCLIC IMMUNOMODULATORS AS INHIBITOR OF IMMUNE RESPONSE CHECKPOINTS PDL1 | 2020 |
|
RU2824127C2 |
